These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 36974836)
1. Development of tLyP-1 functionalized nanoliposomes with tunable internal water phase for glioma targeting. Wang Y; Ding Z; Lv S; Liu J; Pan J; Yu Y; Gao J; Huang X J Liposome Res; 2023 Dec; 33(4):353-367. PubMed ID: 36974836 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and antitumor efficacy of DSPE-PEG2000 polymeric liposomes loaded with quercetin and temozolomide: Analysis of their effectiveness in enhancing the chemosensitization of drug-resistant glioma cells. Hu J; Wang J; Wang G; Yao Z; Dang X Int J Mol Med; 2016 Mar; 37(3):690-702. PubMed ID: 26782731 [TBL] [Abstract][Full Text] [Related]
3. Glioma therapy using tumor homing and penetrating peptide-functionalized PEG-PLA nanoparticles loaded with paclitaxel. Hu Q; Gao X; Gu G; Kang T; Tu Y; Liu Z; Song Q; Yao L; Pang Z; Jiang X; Chen H; Chen J Biomaterials; 2013 Jul; 34(22):5640-50. PubMed ID: 23639530 [TBL] [Abstract][Full Text] [Related]
4. F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery. Hu Q; Gu G; Liu Z; Jiang M; Kang T; Miao D; Tu Y; Pang Z; Song Q; Yao L; Xia H; Chen H; Jiang X; Gao X; Chen J Biomaterials; 2013 Jan; 34(4):1135-45. PubMed ID: 23146434 [TBL] [Abstract][Full Text] [Related]
5. Novel RGD containing, temozolomide-loading nanostructured lipid carriers for glioblastoma multiforme chemotherapy. Song S; Mao G; Du J; Zhu X Drug Deliv; 2016 May; 23(4):1404-8. PubMed ID: 26203687 [TBL] [Abstract][Full Text] [Related]
6. Chemosensitization of Temozolomide-Resistant Pediatric Diffuse Midline Glioma Using Potent Nanoencapsulated Forms of a N(3)-Propargyl Analogue. Heravi Shargh V; Luckett J; Bouzinab K; Paisey S; Turyanska L; Singleton WGB; Lowis S; Gershkovich P; Bradshaw TD; Stevens MFG; Bienemann A; Coyle B ACS Appl Mater Interfaces; 2021 Aug; 13(30):35266-35280. PubMed ID: 34310112 [TBL] [Abstract][Full Text] [Related]
7. Use of Labelled tLyP-1 as a Novel Ligand Targeting the NRP Receptor to Image Glioma. Wu HB; Wang Z; Wang QS; Han YJ; Wang M; Zhou WL; Li HS PLoS One; 2015; 10(9):e0137676. PubMed ID: 26398657 [TBL] [Abstract][Full Text] [Related]
8. Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment. Peng Y; Huang J; Xiao H; Wu T; Shuai X Int J Nanomedicine; 2018; 13():3467-3480. PubMed ID: 29942129 [TBL] [Abstract][Full Text] [Related]
9. Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting. Wang L; Tang S; Yu Y; Lv Y; Wang A; Yan X; Li N; Sha C; Sun K; Li Y Mol Pharm; 2021 Mar; 18(3):915-927. PubMed ID: 33417456 [TBL] [Abstract][Full Text] [Related]
10. Angiopep-2 Grafted PAMAM Dendrimers for the Targeted Delivery of Temozolomide: Sahoo RK; Kumar H; Jain V; Sinha S; Ajazuddin ; Gupta U ACS Biomater Sci Eng; 2023 Jul; 9(7):4288-4301. PubMed ID: 37307155 [TBL] [Abstract][Full Text] [Related]
11. Liposomal temozolomide drug delivery using convection enhanced delivery. Nordling-David MM; Yaffe R; Guez D; Meirow H; Last D; Grad E; Salomon S; Sharabi S; Levi-Kalisman Y; Golomb G; Mardor Y J Control Release; 2017 Sep; 261():138-146. PubMed ID: 28666727 [TBL] [Abstract][Full Text] [Related]
12. Exploring temozolomide encapsulated PEGylated liposomes and lyotropic liquid crystals for effective treatment of glioblastoma: in-vitro, cell line, and pharmacokinetic studies. Waghule T; Laxmi Swetha K; Roy A; Narayan Saha R; Singhvi G Eur J Pharm Biopharm; 2023 May; 186():18-29. PubMed ID: 36924995 [TBL] [Abstract][Full Text] [Related]
13. Environmentally Self-Adaptative Nanocarriers Suppress Glioma Proliferation and Stemness via Codelivery of shCD163 and Doxorubicin. Liu J; Zhang Y; Chen T; Chen H; He H; Jin T; Wang J; Ke Y ACS Appl Mater Interfaces; 2020 Nov; 12(47):52354-52369. PubMed ID: 33196179 [TBL] [Abstract][Full Text] [Related]
14. 'Prodrug-Like' Acetylmannosamine Modified Liposomes Loaded With Arsenic Trioxide for the Treatment of Orthotopic Glioma in Mice. Wang N; Zhang W; Hu D; Jiang L; Liu X; Tang S; Zhou X; Liu T; Tang X; Chai Y; Li M; Peng H; Du Z J Pharm Sci; 2020 Sep; 109(9):2861-2873. PubMed ID: 32534027 [TBL] [Abstract][Full Text] [Related]
15. Tri-block copolymer nanoparticles modified with folic acid for temozolomide delivery in glioblastoma. Emamgholizadeh Minaei S; Khoei S; Khoee S; Karimi MR Int J Biochem Cell Biol; 2019 Mar; 108():72-83. PubMed ID: 30660689 [TBL] [Abstract][Full Text] [Related]
16. Temozolomide-based sonodynamic therapy induces immunogenic cell death in glioma. Zhou Y; Jiao J; Yang R; Wen B; Wu Q; Xu L; Tong X; Yan H Clin Immunol; 2023 Nov; 256():109772. PubMed ID: 37716612 [TBL] [Abstract][Full Text] [Related]
17. Co-administration of dual-targeting nanoparticles with penetration enhancement peptide for antiglioblastoma therapy. Miao D; Jiang M; Liu Z; Gu G; Hu Q; Kang T; Song Q; Yao L; Li W; Gao X; Sun M; Chen J Mol Pharm; 2014 Jan; 11(1):90-101. PubMed ID: 24295590 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and Characterization of a Series of Temozolomide Esters and Its Anti-glioma Study. Yu Y; Wang L; Han J; Wang A; Chu L; Xi X; Kan R; Sha C; Sun K J Pharm Sci; 2021 Oct; 110(10):3431-3438. PubMed ID: 34147518 [TBL] [Abstract][Full Text] [Related]
19. A new molecular probe: An NRP-1 targeting probe for the grading diagnosis of glioma in nude mice. Wu W; Zhong S; Gong Y; Shan Y; Yuan L; Wang L; Chen J; Zhang Z Neurosci Lett; 2020 Jan; 714():134617. PubMed ID: 31705924 [TBL] [Abstract][Full Text] [Related]
20. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery. Belhadj Z; Ying M; Cao X; Hu X; Zhan C; Wei X; Gao J; Wang X; Yan Z; Lu W J Control Release; 2017 Jun; 255():132-141. PubMed ID: 28390902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]